Cognitive decline with nortriptyline use in a patient with dementia of the Alzheimer's type.
作者信息
Bartlomé P, King K S, Matsuo F, Wood J S
机构信息
College of Pharmacy, Department of Pharmacy Practice and Administrative Sciences, Idaho State University, Pocatello 83209.
出版信息
West J Med. 1992 Jan;156(1):75-7.
Abstract
摘要
相似文献
1
Cognitive decline with nortriptyline use in a patient with dementia of the Alzheimer's type.一名阿尔茨海默病型痴呆患者使用去甲替林后出现认知功能减退。
West J Med. 1992 Jan;156(1):75-7.
2
Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍患者的工作记忆与注意力控制
Neuropsychology. 2007 Jul;21(4):458-69. doi: 10.1037/0894-4105.21.4.458.
3
CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.轻度认知障碍和阿尔茨海默病型痴呆患者脑脊液中淀粉样前体蛋白α和磷酸化tau蛋白水平
J Geriatr Psychiatry Neurol. 2009 Mar;22(1):3-9. doi: 10.1177/0891988708327810. Epub 2008 Dec 10.
4
Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.认知储备对西班牙籍散发性阿尔茨海默病患者神经心理功能的影响。
Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):113-22.
5
Dual task performance in early Alzheimer's disease, amnestic mild cognitive impairment and depression.早期阿尔茨海默病、遗忘型轻度认知障碍和抑郁症中的双重任务表现。
Psychol Med. 2009 Jan;39(1):23-31. doi: 10.1017/S0033291708003346. Epub 2008 Apr 15.
6
Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.轻度认知障碍患者的抑郁会增加患阿尔茨海默病型痴呆症的风险：一项前瞻性队列研究。
Arch Neurol. 2004 Aug;61(8):1290-3. doi: 10.1001/archneur.61.8.1290.
7
The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.阿尔茨海默病评估工具使用达成共识的必要性：可行性研究（欧洲各地阿尔茨海默病中心的痴呆评估工具），欧洲阿尔茨海默病协会（EADC）的一项调查。
Int J Geriatr Psychiatry. 2005 Aug;20(8):744-8. doi: 10.1002/gps.1355.
8
[Usage of drugs with potential adverse effects on cognition in a memory-clinic].
Fortschr Neurol Psychiatr. 2009 Sep;77(9):523-7. doi: 10.1055/s-0028-1109625. Epub 2009 Jul 30.
9
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.阿尔茨海默病颞叶的体内质子磁共振波谱分析
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013.
10
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.临床前阿尔茨海默病的认知障碍：一项荟萃分析。
Neuropsychology. 2005 Jul;19(4):520-31. doi: 10.1037/0894-4105.19.4.520.
本文引用的文献
1
Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients.
Br J Psychiatry. 1982 May;140:470-2. doi: 10.1192/bjp.140.5.470.
2
Drug therapy: drug disposition in old age.药物治疗：老年人的药物处置
N Engl J Med. 1982 May 6;306(18):1081-8. doi: 10.1056/NEJM198205063061804.
3
Psychometric differentiation of mild senile dementia of the Alzheimer type.
Arch Neurol. 1984 May;41(5):497-9. doi: 10.1001/archneur.1984.04050170043013.
4
Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.阿尔茨海默病患者和对照组对东莨菪碱的认知和行为敏感性。
Psychopharmacol Bull. 1985;21(3):676-9.
5
Dementia of the Alzheimer's type and depression.阿尔茨海默病型痴呆与抑郁症。
J Am Geriatr Soc. 1986 Dec;34(12):855-9. doi: 10.1111/j.1532-5415.1986.tb07258.x.
6
Diagnosis and treatment of depression in the elderly.
Int J Psychiatry Med. 1988;18(3):211-21. doi: 10.2190/fu3d-eku1-4wxx-jvc9.
7
The reversible dementias: do they reverse?可逆性痴呆：它们会逆转吗？
Ann Intern Med. 1988 Sep 15;109(6):476-86. doi: 10.7326/0003-4819-109-6-476.
8
Psychopharmacological treatment of elderly demented patients.
J Clin Psychiatry. 1988 May;49 Suppl:8-13.
9
Opportunities for psychotherapy in the management of dementia.痴呆症管理中的心理治疗机会。
J Geriatr Psychiatry Neurol. 1989 Jan-Mar;2(1):11-7. doi: 10.1177/089198878900200103.
10
Recognition and treatment of depression in Alzheimer's disease.阿尔茨海默病中抑郁症的识别与治疗
Geriatrics. 1989 Dec;44(12):26-30.
Zotero 插件